Herceptin Followed by Chemotherapy in Treating Women With Metastatic Breast Cancer That Overexpresses HER2
Stopped Trial is Life long follow-up: to reduce ressources and costs - trial terminated prematurely.
Conditions
Interventions
- DRUG: Herceptin™ (Her)
- DRUG: Herceptin™ (Her) + chemo
Sponsor
Swiss Cancer Institute